Short versus prolonged dual antiplatelet therapy (DAPT) duration after coronary stent implantation: A comparison between the DAPT study and 9 other trials evaluating DAPT duration
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference18 articles.
1. 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions;GN Levine;Circulation,2011
2. Short versus long duration of DAPT after DES implantation: a meta-analysis;GG Stefanini;J Am Coll Cardiol,2014
3. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI);S Windecker;Eur Heart J,2014
4. Twelve or 30 Months of Dual Antiplatelet Therapy after Drug-Eluting Stents;L Mauri;N Engl J Med,2014
5. Higgins J, Green S, (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. www.cochrane-handbook.org.
Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. De-Escalation Therapy After PCI in ACS Patients With Chronic Kidney Disease;JACC: Asia;2023-02
2. Comparison and Validation of Long-Term Bleeding Events for Academic Bleeding Risk (ARC-HBR) Criteria and Contemporary Risk Scores for Percutaneous Coronary Intervention With a Second-Generation Drug Eluting Stent;Circulation Journal;2022-08-25
3. Early P2Y<sub>12</sub> Inhibitor Single Antiplatelet Therapy for High-Bleeding Risk Patients After Stenting ― PENDULUM Mono 24-Month Analysis ―;Circulation Journal;2022-08-25
4. Extended, standard, or De-escalation antiplatelet therapy for patients with coronary artery disease undergoing percutaneous coronary intervention? A trial-sequential, bivariate, influential, and network meta-analysis;European Heart Journal - Cardiovascular Pharmacotherapy;2022-03-24
5. Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives;Cardiovascular Intervention and Therapeutics;2022-03-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3